文献速递腹部技术与安全MRUS

超声造影对高危肝细胞癌患者MRI不确定观察的解决作用

Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

研究纳入42例高危肝细胞癌患者共50个MRI不确定结节样观察和10个动脉期高增强灶,用超声造影按LI-RADS盲法分类并与病理及24个月随访对照。超声造影在14/37(38%)动脉期增强无廓清的结节中显示廓清,诊断16个恶性病灶(14个HCC、2个ICC),敏感度81.3%、特异度100%,36%患者LI-RADS从LR-3或4升级至LR-4或5。

要点

  • 灰阶超声可识别真结节并与假病灶区分。
  • 动态超声造影可检测廓清并正确预测HCC。
  • MRI不确定时超声造影可作为问题解决工具。

核心结论

  • 灰阶超声检测真结节,动态超声造影检测并定性廓清,正确预测HCC。
  • 超声造影是MRI的补充,当MRI不确定时可作为问题解决工具。

研究设计与样本

  • 研究类型为单中心连续病例队列,2015年7月至12月连续纳入42例因MRI不确定转诊超声造影的高危HCC患者。
  • 共50个不确定结节样观察和10个动脉期高增强灶(提示假病灶/动门静脉分流)。
  • MRI和超声造影按各期增强特征及LI-RADS盲法分类,行临床病理对照和24个月随访。

关键影像表现/征象

  • 37/50(74%)不确定结节样观察在MRI上呈动脉期增强而无廓清。
  • 超声造影进一步定性增强并在14/37(38%)中显示廓清。
  • 10个MRI疑似动门静脉分流中,2个在超声上显示真结节,分别证实为HCC和再生结节。

诊断标准与关键数值

  • 超声造影诊断16个恶性病灶(14例患者中14个HCC、2个ICC),其中12/16(75%)经活检或随访证实。
  • 超声造影诊断恶性的敏感度为(13/16)81.3%,特异度为(37/37)100%。
  • 15/42(36%)患者LI-RADS从MRI的LR-3或4升级至超声造影的LR-4或5。

临床应用与阅片要点

  • 灰阶超声识别真结节,有助于将真结节与假病灶区分。
  • 动态超声造影检测并定性廓清,可正确预测HCC。
  • MRI不确定时,超声造影可作为补充的问题解决工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To show the contribution of CEUS to characterization of indeterminate MRI observations in high-risk patients for hepatocellular carcinoma (HCC).

METHODS: From July to December 2015, 42 consecutive patients referred to CEUS with indeterminate MRI scans comprise our study cohort. There are 50 indeterminate nodule-like observations and 10 arterial phase hyperenhancing foci, suggesting pseudolesions/arterio-portal shunts. MRI and CEUS lesions are classified according to their enhancement features in all phases and Liver Imaging and Reporting Data System (LI-RADS) in a blind read format. Clinical pathologic correlation and 24 months follow-up are performed.

RESULTS: A majority, 37/50 (74%), of indeterminate nodule-like observations have arterial phase enhancement without washout on MRI. CEUS further characterizes enhancement and shows washout in 14/37 (38%). In total, CEUS diagnoses 16 malignant lesions in 14 patients including 14 HCC and 2 ICC. 12/16 (75%) malignant lesions are confirmed by biopsy or follow-up. Ultrasound identification of a nodule differentiates real nodules from pseudolesions. Of the ten suspected arterial-portal shunts on MRI, two show a real nodule on ultrasound, confirmed as an HCC and a regenerative nodule. 15/42 (36%) patients have LI-RADS escalated from LR-3 or 4 on MRI to LR-4 or 5 on CEUS. Overall, the sensitivity of CEUS is (13/16) 81.3% and specificity is (37/37) 100% for malignant diagnosis.

CONCLUSION: Grayscale ultrasound detects true nodules. Dynamic CEUS detects and characterizes washout, correctly predicting HCC. CEUS is complimentary to MRI and can serve as a problem-solving tool when MRI is indeterminate.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Hu J, Bhayana D, Burak KW, et al. Resolution of indeterminate MRI with CEUS in patients at high risk for hepatocellular carcinoma. Abdom Radiol (NY). 2020. PMID: 31440801. doi:10.1007/s00261-019-02181-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。